Robert Landry
Director of Finance/CFO presso CHECKMATE PHARMACEUTICALS, INC.
Patrimonio netto: 23 M $ in data 31/03/2024
Profilo
Robert E. Landry è direttore finanziario e vicepresidente esecutivo di Regeneron Pharmaceuticals, Inc. In precedenza è stato tesoriere e vicepresidente senior presso Pfizer Inc. Direttore del marketing farmaceutico e delle vendite alla Wyeth Australia Pty Ltd. Chief Financial Officer di Wyeth New Zealand e Treasurer & Principal Corporate Officer presso Wyeth Corp. (che sono tutte filiali di Pfizer Inc.). Il sig. Landry ha conseguito una laurea presso l'Università di Notre Dame.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 02/02/2024 | 23 963 ( 0.02% ) | 23 M $ | 31/03/2024 |
Posizioni attive di Robert Landry
| Società | Posizione | Inizio |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Director of Finance/CFO | 31/05/2022 |
| DECIBEL THERAPEUTICS, INC. | Director of Finance/CFO | 22/09/2023 |
Precedenti posizioni note di Robert Landry
| Società | Posizione | Fine |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Director of Finance/CFO | 05/02/2024 |
| PFIZER, INC. | Corporate Officer/Principal | 01/10/2012 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Treasurer | 01/10/2009 |
| Wyeth Australia Pty Ltd. | Director of Finance/CFO | 01/01/2006 |
| Wyeth New Zealand | Director of Finance/CFO | 01/01/2006 |
Formazione di Robert Landry
| University of Notre Dame | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| DECIBEL THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
| Wyeth Australia Pty Ltd. | |
| Wyeth New Zealand | |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Robert Landry
